Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-03

Clinical Trial Update: Nigella Sativa Oil Extract and Xenograft Bone Graft in Treatment of Infra-bony Defects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Nigella Sativa oil extract and xenograft bone graft for treatment of infra-bony defects in localized aggressive periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nigella sativa oil extract
  • Xenograft bone graft (Xenograft bone graft material)

Snippet

Sponsor: Tanta University | Conditions: Localized Aggressive Periodontitis | Phase 2 | Status: UNKNOWN